Return to the home page. top banner right
top banner bottom
Click to search.
members
Login:
Password:
Click to login
Click for Log In Help
Click to Join the Society
 
 
 
 
Click for the Heart Rhythm Foundation
Click for the IBHRE (formerly NASPExAM)
Click for Professional Education
Click for Health Policy
 
 
 
 
 
Click for Clinical Guidance
Click for Research
Click for News & Information
Click for Scientific Sessions
Click for the HRS Calendar
Click for the HeartRhythm Journal
Click for the HRS Store
Click to Find a Specialist
Click for Patient Information
Click for About HRS
Click for Membership
Click for Career Center
Click for the AF 360° Resource Center
Click for the SCA 360° Resource Center
titlelines Counterfeit Alli Dosing Concerns
The U.S. Food and Drug Administration has updated a January 18, 2010 alert with information on laboratory analysis of sibutramine levels in a counterfeit product: Alli 60 mg capsules (120 count refill kit).
content_line

Alli 60 mg Capsules (120 Count Refill Kit): Counterfeit Product

The U.S. Food and Drug Administration has issued the following alert:

FDA laboratory tests on the counterfeit product show that people may be taking three times the usual daily dose (or twice the recommended maximum dose) of sibutramine if they are following the dosing directions for Alli.

Healthy people who take this much sibutramine can experience anxiety, nausea, heart palpitations, tachycardia (a racing heart), insomnia, and small increases in blood pressure.

This excessive amount of sibutramine is dangerous to people who have a history of cardiovascular disease, and can lead to elevated blood pressure, stroke, or heart attack.

Read the MedWatch 2010 Safety summary, including a link to both the original January 18 alert and the Update, on the FDA website.

Click to Email Page. Click to Print Page.
Click to Contact Us.Click for the Site Map.
© Heart Rhythm Society | 1400 K St. NW, Suite 500 | Washington DC 20005 | (202) 464-3400 | Fax: (202) 464-3401 | Privacy Policy